Statin Discontinuation in Elderly Shows No Mortality Increase in Small Trial
A modest randomized trial found that stopping primary prevention statins in older adults did not increase mortality risk. However, experts remain uncertain about the overall benefit of discontinuation.
Related stories
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Stopping Statins in Trial Didn't Raise Mortality Risk, but ....” Browse more stories.